US2022273589A1PendingUtilityA1
Diagnosis and Treatment of Vitiligo
Est. expiryApr 24, 2037(~10.7 yrs left)· nominal 20-yr term from priority
A61K 45/06C07K 2317/76C07K 14/705C07K 16/2866A61K 31/137C07K 2317/71A61P 17/00C07K 14/7155A61K 2039/505C07K 2317/524C07K 2317/24A61P 37/06
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of diagnosing and treating vitiligo.
Claims
exact text as granted — not AI-modified1 .- 5 . (canceled)
6 . A method of treating a subject who has a vitiligo lesion, the method comprising:
identifying a subject in need of treatment; and administering a therapeutically effective amount of an inhibitor of Sphingosine-1-phosphate receptor 1 (S1P1) to the subject.
7 . The method of claim 6 , wherein the inhibitor of S1P1 is Fingolimod.
8 .- 19 . (canceled)
20 . The method of claim 6 , wherein the inhibitor is administered to the lesion.
21 . The method of claim 20 , wherein the inhibitor is administered to the epidermis within the lesion.
22 . The method of claim 20 , wherein the inhibitor is administered to the epidermis within the lesion by subcutaneous or intradermal administration, or a microneedle array.Join the waitlist — get patent alerts
Track US2022273589A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.